InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Aslan Fred. Officer active across 1 company, notably Artiva Biotherapeutics, Inc.. Cumulatively, 2 reports have been published. Activity tracked since 22 July 2024. The latest transaction was disclosed on 5 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations